摘要
生物医药产业是国民经济的重要组成部分,药品安全直接关系到人民的生命健康,是社会稳定和经济发展的重要保障。为切实保障药品安全、促进生物医药产业创新发展和转型升级,国家层面和各省(自治区、直辖市)政府相继制定出台了“十四五”药品安全监管及促进高质量发展规划,本文介绍了国家层面的《“十四五”国家药品安全及促进高质量发展规划》,并对各省(自治区、直辖市)的共性措施以及特色举措进行了分析和比较。
Biopharmaceutical industry is an important part of the national economy.Drug safety is directly related to people's life and health,which is an important guarantee for social stability and economic development.In order to effectively ensure drug safety and promote the innovative development,transformation and upgrading of the biomedical industry,the national level and provincial(autonomous region,province-level municipality) governments have successively formulated and issued the “14th Five-Year Plan” for drug safety supervision and promoting high-quality development.This paper introduces the national “14th Five-Year Plan” for drug safety and promoting high-quality development at the national level.It also analyzes and compares the common measures and characteristic measures of different provinces(autonomous regions and province-level municipalities).
作者
何辉
唐湘燕
周刚
HE Hui;TANG Xiang-yan;ZHOU Gang(Center for Drug Evaluation,National Medical Products Administration,Beijing 100061,China)
出处
《中国新药杂志》
CAS
CSCD
北大核心
2023年第14期1385-1391,共7页
Chinese Journal of New Drugs
关键词
药品安全监管
“十四五”规划
药品高质量发展
drug safety supervision
the 14th Five-Year Plan
high quality development of drugs